Cargando…

Transmission Dynamics and Epidemiological Characteristics of the SARS-CoV-2 Delta Variant ― Hunan Province, China, 2021

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Little is known about the epidemiology, natural history, and transmission patterns of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant. Monitoring the evolution of viral fitness of SARS-CoV-2 in the host population is key for prep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Kaiwei, Wu, Yanpeng, Wang, Yan, Liu, Ziyan, Yi, Lan, Zhao, Shanlu, Yan, Xuemei, Yang, Hao, Sun, Kaiyuan, Ajelli, Marco, Hu, Shixiong, Yu, Hongjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:	Preplanned Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902755/ https://www.ncbi.nlm.nih.gov/pubmed/36776461 http://dx.doi.org/10.46234/ccdcw2023.011

Ejemplares similares

Integrated Rabies Surveillance — Hunan Province, China, 2020
por: Yang, Hao, et al.
Publicado: (2022)

Comparison of Omicron and Delta Variant Infection COVID-19 Cases — Guangdong Province, China, 2022
por: Hu, Ting, et al.
Publicado: (2022)

Risk Factors Associated with the Spatiotemporal Spread of the SARS-CoV-2 Omicron BA.2 Variant — Shanghai Municipality, China, 2022
por: Zheng, Wen, et al.
Publicado: (2023)

A follow up study of cycle threshold values of SARS-CoV-2 in Hunan Province, China
por: Abudurusuli, Guzainuer, et al.
Publicado: (2023)

Field Simulation of Aerosol Transmission of SARS-CoV-2 in a Special Building Layout — Guangdong Province, China, 2021
por: Zhang, Zhuona, et al.
Publicado: (2021)

A Retrospective Modeling Study of the Targeted Non-Pharmaceutical Interventions During the Xinfadi Outbreak in the Early Stage of the COVID-19 Pandemic — Beijing, China, 2020
por: Wang, Yan, et al.
Publicado: (2023)

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
por: Li, Mingshuang, et al.
Publicado: (2022)

Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study — Yunnan Province, China, 2021–2022
por: Yang, Haitao, et al.
Publicado: (2023)

Self-Reported Food Allergy Prevalence Among Elementary School Children — Nanchang City, Jiangxi Province, China, 2021
por: Feng, Hua, et al.
Publicado: (2022)

Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China
por: Hu, Shixiong, et al.
Publicado: (2021)

Effectiveness of Inactivated COVID-19 Vaccines Against Symptomatic, Pneumonia, and Severe Disease Caused by the Delta Variant: Real World Study and Evidence — China, 2021
por: Wu, Dan, et al.
Publicado: (2022)

COVID-19 Vaccination Rates of People Who Use Drugs — Chengdu City, Sichuan Province, China, November 2021 – February 2022
por: Du, Erri, et al.
Publicado: (2022)

Willingness of Caregivers to Have Their Children Vaccinated with Pneumococcal Vaccines in the Context of an Innovative Immunization Strategy — Weifang City, Shandong Province, 2021
por: Yang, Yuan, et al.
Publicado: (2022)

Reappearance of Risk of Schistosomiasis Transmission and the Response After 27 Years of Interrupted Transmission — Guangdong Province, China, 2019
por: Huang, Shaoyu, et al.
Publicado: (2021)

Epidemiological Characteristics of Visceral Leishmaniasis — Shanxi Province, China, 1950–2019
por: Zhao, Yingze, et al.
Publicado: (2022)

Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China
por: Hu, Shixiong, et al.
Publicado: (2021)

Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China
por: Hu, Shixiong, et al.
Publicado: (2021)

Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2
por: Sun, Kaiyuan, et al.
Publicado: (2021)

Surveillance and Response to Imported Malaria During the COVID-19 Epidemic — Anhui Province, China, 2019–2021
por: Zhang, Tao, et al.
Publicado: (2022)

Epidemiological Characteristics of Osteoarthritis in Yichang City — Hubei Province, China, 2017–2018
por: Zhang, Yingying, et al.
Publicado: (2021)

Enterohemorrhagic Escherichia coli O157:H7 — Xuzhou City, Jiangsu Province, China, 2001–2021
por: Zhu, Wenwen, et al.
Publicado: (2023)

Rapid Assessment on Potential Risks of Schistosomiasis Transmission — 7 PLADs, China, 2019 and 2021
por: He, Junyi, et al.
Publicado: (2021)

Malaria Surveillance of Entry People During the COVID-19 Epidemic — Guangdong Province, China, October 2020–May 2021
por: Wu, De, et al.
Publicado: (2021)

Associations of Occupational Stress and Coping Styles with Well-Being Among Couriers — Three Cities, Zhejiang Province, China, 2021
por: Xue, Panqi, et al.
Publicado: (2023)

Unhealthy Eating Behaviors During Pregnancy and Gestational Weight Gain — Huai’an City, Jiangsu Province, China, 2020–2021
por: Zhang, Zifan, et al.
Publicado: (2023)

The Spectrum and Age-Sex Patterns Among Outpatients with Allergic Diseases — Yichang City, Hubei Province, China, 2018–2021
por: Wang, Jinyi, et al.
Publicado: (2023)

Effectiveness of Interventions to Control Transmission of Reemergent Cases of COVID-19 — Jilin Province, China, 2020
por: Zhao, Qinglong, et al.
Publicado: (2020)

Factors Associated with PCV13 Vaccine Hesitancy in Parents under an Innovative Immunization Strategy: a Cross-Sectional Study — Weifang City, Shandong Province, China, 2021
por: Du, Yuanze, et al.
Publicado: (2023)

Multiple Center Research on Relationship Between Screening Quality and Detection of Cervical Cancer — Six Provinces, China, June–December 2021
por: Zhang, Xiaosong, et al.
Publicado: (2023)

Identification of Novel Bartonella washoensis Sequence Type 22 in Marmota himalayana — Jiuquan City, Gansu Province, China, 2021–2022
por: Duan, Ran, et al.
Publicado: (2023)

Antibody Response to COVID-19 Virus — Heilongjiang Province and Gansu Province, China, 2020
por: Mao, Naiying, et al.
Publicado: (2020)

Assessment of the Transmission Risk of Schistosomiasis after Flooding — North Poyang Lake, Jiangxi Province, China, 2020
por: Lv, Shan, et al.
Publicado: (2021)

Aerosol Transmission of SARS-CoV-2 in Two Dormitories — Hubei and Shandong Provinces, China, 2020
por: Li, Xiaofeng, et al.
Publicado: (2022)

Epidemiological and Clinical Features of Patients with Scrub Typhus — Guangzhou City, Guangdong Province, China, 2012–2018
por: Wei, Yuehong, et al.
Publicado: (2021)

Coverage of 13-Valent Pneumococcal Conjugate Vaccine Among Children 0–15 Months of Age — 9 Provinces, China, 2019–2021
por: Liu, Lijun, et al.
Publicado: (2023)

SARS-CoV-2 Aerosol Transmission Through Vertical Sanitary Drains in High-Rise Buildings — Shenzhen, Guangdong Province, China, March 2022
por: Lyu, Keyang, et al.
Publicado: (2022)

Change of Disease Spectrum Characteristics of Psychiatric Inpatients Before and After Lockdown Lifted During the COVID-19 Pandemic — Wuhan City, Hubei Province, China, 2021
por: Liu, Jingfang, et al.
Publicado: (2022)

Prevalence of High-Risk Human Papillomavirus by Subtypes Among Rural Women Aged 35–64 Years — Guangzhou City, Guangdong Province, China, 2019–2021
por: Shao, Dantong, et al.
Publicado: (2022)

Evaluation of Smoking Cessation Intervention Effectiveness in Smoking Cessation Clinics — China, 2019–2021
por: Xie, Li, et al.
Publicado: (2023)

The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant — Guangdong Province, China, December 2022 to January 2023
por: Cai, Chunsheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2nuh9f92t42t0130mki79v02pn